We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trésorerie de 6,8 millions d'euros au 31 décembre 2023. Visibilité financière jusqu'à la fin du 4e trimestre 2024. Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO...
Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après " Valerio Therapeutics " ou la " Société ", société de biotechnologie au stade clinique spécialisée dans le...
Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) Under the liquidity contract entered into between Valerio Therapeutics and Kepler Cheuvreux, the following resources...
New identity unveiled, with the aim at developing innovative therapies against cancer R&D efforts maintained for VIO-01 (formerly OX425) and AsiDNATM Optimization of PlatONTM platform...
Regulatory News: Au titre du contrat de liquidité confié par la société VALERIO THERAPEUTICS (Paris:ALVIO) à Kepler Cheuvreux, à la date du 30 juin 2023, les moyens suivants figuraient au compte...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0068 | -5.91304347826 | 0.115 | 0.115 | 0.1074 | 87183 | 0.10957212 | DE |
4 | -0.008 | -6.88468158348 | 0.1162 | 0.117 | 0.107 | 58659 | 0.11066763 | DE |
12 | -0.0118 | -9.83333333333 | 0.12 | 0.138 | 0.09 | 75577 | 0.11453976 | DE |
26 | -0.0773 | -41.6711590296 | 0.1855 | 0.1855 | 0.09 | 87462 | 0.13034099 | DE |
52 | -0.1648 | -60.3663003663 | 0.273 | 0.348 | 0.09 | 81279 | 0.18946951 | DE |
156 | -0.1648 | -60.3663003663 | 0.273 | 0.348 | 0.09 | 81279 | 0.18946951 | DE |
260 | -0.1648 | -60.3663003663 | 0.273 | 0.348 | 0.09 | 81279 | 0.18946951 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions